S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.10
+62.50
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
BRKR · Bruker Corporation
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
Bruker Corp (BRKR)
NASDAQ NMS - GLOBAL MARKET
Life Sciences Tools & Services
$59.09
+3.15
(+5.63%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$59.09
$56.08
$59.48
52-WEEK RANGE
$59.09
$32.37
$66.98
What's happening
- BRKR is up 5.63% today, trading at $59.09. — Live quote
- Volume today (362,096) is well below its 3-month average of 2,237,290. (Finnhub fundamentals)
- Reports earnings on 2026-11-04 (before market open), 13 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $0.49 actual vs. $0.39 estimated (+24.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 6
Buy 6
Hold 7
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (20 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
BRKR
+25.46%
vs S&P 500
+12.09%
1-YEAR RETURN
BRKR
+52.41%
vs S&P 500
+37.25%
6-MONTH RETURN
BRKR
+45.22%
3-MONTH RETURN
BRKR
-1.06%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.49
Est. $0.39
BEAT +24.9%
2026-04-26 (Q1 2026)
$0.31
Est. $0.24
BEAT +30.1%
2026-01-26 (Q4 2025)
$0.59
Est. $0.66
MISS -10.9%
2025-10-26 (Q3 2025)
$0.45
Est. $0.34
BEAT +31.7%
Valuation Measures & Ratios
Enterprise Value4$10.61B
Forward P/E526.28
PEG Ratio61.79
Price / Sales (TTM1)2.56
Price / Book73.85
EV4 / Revenue3.03
EV4 / EBITDA60.05
Profit Margin-2.03%
Operating Margin-1.53%
Return on Equity (ROE8)-2.93%
Return on Assets (ROA9)-1.15%
Avg Volume (3M)2,237,290
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $7.63B | $25.96B | $4.70B | $6.23B | $6.56B |
| P/E | -85.13 | -1284.95 | 746.21 | 84.77 | 56.14 |
| Price/Sales | 2.30 | 7.91 | 1.41 | 1.91 | 2.06 |
| Price/Book | — | — | 1.93 | — | — |
| EV/Revenue | 2.79 | 8.37 | 1.92 | 2.61 | 2.65 |
| EV/EBITDA | 69.55 | 123.47 | 23.40 | — | — |
| ROE | — | — | 0.26% | — | — |
| ROA | -1.48% | -0.33% | 0.10% | 1.16% | 1.97% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short12,406,174
Change from Prior Settlement-0.67%
% of Float—
Days to Cover (Short Ratio)5.09
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 5.2% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +52.4%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is -2.0%. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-16; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on BRKR
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $838.5M | $823.4M | $860.5M | $797.4M | $801.4M | $864.4M | $800.7M | $721.7M |
| Gross profit | $416.0M | $379.8M | $379.4M | $357.9M | $391.2M | $418.8M | $384.6M | $352.8M |
| Operating income | -$65.3M | $10.2M | -$51.8M | $11.9M | $31.8M | $68.1M | $48.1M | $64.8M |
| Net income | -$52.0M | $14.4M | -$59.6M | $7.6M | $17.4M | $40.9M | $7.6M | $50.9M |
| EPS (diluted) | $-0.41 | $0.02 | $-0.41 | $0.05 | $0.11 | $0.27 | $0.05 | $0.35 |
| EPS (basic) | $-0.41 | $0.02 | $-0.41 | $0.05 | $0.11 | $0.27 | $0.05 | $0.35 |
| Operating margin | -$8 | $1 | -$6 | $1 | $4 | $8 | $6 | $9 |
| Net margin | -$6 | $2 | -$7 | $1 | $2 | $5 | $1 | $7 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $6.05B | $6.13B | $6.24B | $6.43B | $6.34B | $5.93B | $5.81B | $6.11B |
| Total liabilities | — | — | $3.73B | — | — | — | $3.99B | $4.27B |
| Stockholders' equity | — | — | $2.46B | $2.43B | — | — | $1.78B | $1.81B |
| Total current assets | $2.23B | $2.10B | $2.21B | $2.35B | $2.16B | $2.11B | $2.05B | $2.19B |
| Total current liabilities | $1.20B | $1.36B | $1.28B | $1.27B | $1.35B | $1.34B | $1.28B | $1.32B |
| Cash & equivalents | $184.9M | $133.4M | $298.8M | $293.1M | $92.0M | $184.2M | $183.4M | $148.1M |
| Marketable securities (current) | — | — | — | — | — | — | — | — |
| Accounts receivable | $545.9M | $542.7M | $544.9M | $550.9M | $522.6M | $537.8M | $565.5M | $538.4M |
| Inventory | $1.12B | $1.12B | $1.09B | $1.20B | $1.22B | $1.12B | $1.07B | $1.22B |
| Other current assets | $374.1M | $306.0M | $274.2M | $310.0M | $329.8M | $273.0M | $236.5M | $284.5M |
| Property, plant & equipment | $714.1M | $719.6M | $744.8M | $746.7M | $758.5M | $689.0M | $669.3M | $693.9M |
| Goodwill | $1.43B | $1.57B | $1.55B | $1.55B | $1.65B | $1.53B | $1.51B | $1.47B |
| Intangible assets | $867.8M | $902.4M | $899.6M | $918.9M | $969.6M | $901.7M | $912.5M | $1.03B |
| Other non-current assets | $816.2M | $832.2M | $836.8M | $868.8M | $799.8M | $698.0M | $232.7M | $238.1M |
| Accounts payable | $200.2M | $269.1M | $215.9M | $184.4M | $243.0M | $244.6M | $234.1M | $227.5M |
| Deferred revenue (current) | $444.6M | $479.7M | $441.3M | $455.4M | $478.1M | $470.6M | $438.2M | $466.7M |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $549.8M | $597.9M | $605.4M | $604.0M | $570.6M | $592.0M | $576.5M | $595.1M |
| Long-term debt | $1.81B | $1.66B | $1.85B | $1.98B | $2.38B | $2.08B | $2.06B | $2.26B |
| Other non-current liabilities | $597.7M | $609.9M | $599.4M | $690.2M | $746.0M | $660.9M | $311.0M | $206.3M |
| Common stock & paid-in capital | — | — | $1.8M | $1.8M | — | — | $1.8M | — |
| Retained earnings | — | — | $2.36B | $2.35B | — | — | $2.41B | $2.40B |
| Accumulated other comprehensive income (loss) | — | — | -$79.5M | -$79.2M | — | — | -$103.5M | -$62.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$77.4M | $71.2M | $229.8M | -$33.2M | -$127.5M | $65.0M | $190.0M | $38.4M |
| Investing cash flow | -$25.3M | -$39.7M | -$55.5M | -$23.8M | -$91.1M | -$26.1M | -$60.6M | -$67.6M |
| Financing cash flow | $149.2M | -$204.9M | -$167.6M | $258.4M | $95.5M | -$51.2M | -$75.0M | -$2.7M |
| Free cash flow | -$106.2M | $47.0M | $207.2M | -$54.1M | -$148.8M | $39.0M | $153.3M | $5.8M |
| Capital expenditures | $28.8M | $24.2M | $22.6M | $20.9M | $21.3M | $26.0M | $36.7M | $32.6M |
| Depreciation & amortization | $58.0M | $58.3M | $169.9M | $55.7M | $56.1M | $50.4M | $149.1M | $51.0M |
| Share-based compensation | — | — | $20.2M | — | — | — | $6.8M | $6.3M |
| Deferred income taxes | -$31.1M | — | -$39.3M | -$26.6M | -$15.9M | -$22.7M | -$19.6M | -$21.9M |
| Change in accounts receivable | — | — | -$54.2M | — | — | — | $51.3M | $18.8M |
| Change in inventory | $23.7M | $47.2M | -$68.9M | — | $28.4M | $28.4M | -$35.3M | $11.1M |
| Change in accounts payable | — | — | -$37.5M | — | — | — | $20.8M | — |
| Purchases of investments | — | — | — | — | — | — | — | — |
| Other investing activities | -$3.5M | -$500.0K | -$7.9M | $2.7M | $1.4M | -$1.0M | -$47.3M | $34.8M |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | $0 | $0 | $0 | $0 | $10.0M | $0 | $0 |
| Debt issued | $0 | $0 | $600.0K | $0 | $0 | $2.9M | $1.2M | $166.8M |
| Debt repaid | $2.3M | $181.3M | $145.2M | $299.0M | $14.6M | $7.7M | $7.6M | $9.8M |
| Other financing activities | $0 | -$5.0M | -$9.4M | $11.2M | -$9.4M | -$700.0K | -$17.0M | -$900.0K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B |
| Gross profit | $1.58B | $1.65B | $1.51B | $1.31B | $1.21B |
| Operating income | $68.2M | $253.1M | $436.9M | $432.7M | $413.3M |
| Net income | -$8.6M | $113.1M | $427.2M | $296.6M | $277.1M |
| EPS (diluted) | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 |
| EPS (basic) | $-0.15 | $0.76 | $2.92 | $2.00 | $1.83 |
| Operating margin | $2 | $8 | $15 | $17 | $17 |
| Net margin | -$0 | $3 | $14 | $12 | $11 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $6.24B | $5.81B | $4.25B | $3.61B | $3.65B |
| Total liabilities | $3.73B | $3.99B | $2.84B | $2.48B | — |
| Stockholders' equity | $2.46B | $1.78B | $1.38B | $1.11B | $1.07B |
| Total current assets | $2.21B | $2.05B | $2.16B | $2.11B | $2.47B |
| Total current liabilities | $1.28B | $1.28B | $1.20B | $914.3M | $938.5M |
| Cash & equivalents | $298.8M | $183.4M | $488.3M | $645.5M | $1.07B |
| Marketable securities (current) | — | — | — | $0 | $100.0M |
| Accounts receivable | $544.9M | $565.5M | $492.0M | $472.7M | $416.9M |
| Inventory | $1.09B | $1.07B | $968.3M | $800.1M | $710.1M |
| Other current assets | $274.2M | $236.5M | $215.6M | $193.5M | $172.2M |
| Property, plant & equipment | $744.8M | $669.3M | $599.7M | $487.0M | $406.1M |
| Goodwill | $1.55B | $1.51B | $582.6M | $457.6M | $339.5M |
| Intangible assets | $899.6M | $912.5M | $330.5M | $270.9M | $211.8M |
| Other non-current assets | $249.3M | $232.7M | $184.0M | $155.1M | $70.8M |
| Accounts payable | $215.9M | $234.1M | $202.7M | $178.4M | $147.4M |
| Deferred revenue (current) | $441.3M | $438.2M | — | $218.0M | $197.5M |
| Short-term debt | — | — | — | — | — |
| Other current liabilities | $605.4M | $576.5M | $478.2M | $347.0M | $481.2M |
| Long-term debt | $1.85B | $2.06B | $1.16B | $1.20B | $1.22B |
| Other non-current liabilities | $239.2M | $311.0M | $240.2M | $120.8M | $162.2M |
| Common stock & paid-in capital | $1.8M | $1.8M | — | — | — |
| Retained earnings | $2.36B | $2.41B | $2.32B | $1.93B | $1.66B |
| Accumulated other comprehensive income (loss) | -$79.5M | -$103.5M | $6.0M | $14.8M | -$8.2M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $134.1M | $251.3M | $350.1M | $274.4M | $282.4M |
| Investing cash flow | -$196.5M | -$1.76B | -$326.0M | -$251.6M | -$192.4M |
| Financing cash flow | $135.1M | $1.23B | -$193.4M | -$415.3M | $318.7M |
| Free cash flow | $43.3M | $136.0M | $243.2M | $145.2M | $190.4M |
| Capital expenditures | $90.8M | $115.3M | $106.9M | $129.2M | $92.0M |
| Depreciation & amortization | $220.3M | $183.8M | $114.9M | $88.8M | $89.1M |
| Share-based compensation | $20.2M | $25.3M | $30.9M | $27.7M | $17.2M |
| Deferred income taxes | -$104.5M | -$63.8M | -$24.4M | -$14.8M | -$5.8M |
| Change in accounts receivable | -$54.2M | $40.6M | $900.0K | $67.9M | $95.3M |
| Change in inventory | -$12.1M | $69.8M | $125.0M | $137.9M | $67.0M |
| Change in accounts payable | -$37.5M | $20.8M | $1.2M | $33.3M | — |
| Purchases of investments | — | — | — | — | — |
| Other investing activities | -$4.8M | -$5.9M | -$32.3M | — | — |
| Share repurchases | $10.0M | $0 | $152.3M | $263.1M | $153.3M |
| Debt issued | $3.5M | $973.7M | $2.0M | $300.0K | $492.8M |
| Debt repaid | $466.5M | $135.4M | $23.5M | $111.0M | $800.0K |
| Other financing activities | -$8.3M | -$24.9M | $300.0K | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding BRKR as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-15 to 2026-09-15
Recent transactions
- Insiders have net sold 13,473 shares over the last 182 days, across 0 purchases and 6 sales.
- Most recent: Munch Mark (EXEC VP&PRES BRUKER NANO INC.) — Option exercise of 2,000 shares on 2026-09-15.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)13,473 sh(6 txns)
Net Shares-13,473
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2026-09-15 | 2,000 |
| Pusch Wolfgang | President BMID Group | Open market sale | 2026-08-17 | 3,473 |
| Prause Burkhard | PRES. & CEO, BRUKER BEST | Grant / award | 2026-08-15 | 3,303 |
| Bures Thomas | Chief Accounting Officer | Grant / award | 2026-08-15 | 4,035 |
| Srega Juergen | PRESIDENT CALID | Grant / award | 2026-08-15 | 16,898 |
| LAUKIEN FRANK H | PRESIDENT & CEO | Grant / award | 2026-08-15 | 29,463 |
| Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | Grant / award | 2026-08-15 | 15,794 |
| Bernard Thierry | Reporting person | Grant / award | 2026-05-15 | 2,886 |
| FRANCIS LAURA | Reporting person | Grant / award | 2026-02-15 | 4,520 |
| Phillips Jack | Reporting person | Grant / award | 2026-02-15 | 4,520 |
| ORNELL JOHN A | Reporting person | Grant / award | 2026-02-15 | 4,520 |
| LINTON WILLIAM A | Reporting person | Grant / award | 2026-02-15 | 4,520 |
| Perkins Adelene Q | Reporting person | Grant / award | 2026-02-15 | 4,520 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-09-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $52.87 |
| 2026-08-17 | Pusch Wolfgang | President BMID Group | Open market sale | 3,473 | $56.90 |
| 2026-08-15 | Prause Burkhard | PRES. & CEO, BRUKER BEST | Grant / award | 3,303 | $0.00 |
| 2026-08-15 | Pusch Wolfgang | President BMID Group | Grant / award | 3,120 | $0.00 |
| 2026-08-15 | Bures Thomas | Chief Accounting Officer | Grant / award | 4,035 | $0.00 |
| 2026-08-15 | Srega Juergen | PRESIDENT CALID | Grant / award | 16,898 | $0.00 |
| 2026-08-15 | LAUKIEN FRANK H | PRESIDENT & CEO | Grant / award | 29,463 | $0.00 |
| 2026-08-15 | LAUKIEN FRANK H | PRESIDENT & CEO | Tax withholding | 4,760 | $57.70 |
| 2026-08-15 | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | Grant / award | 15,794 | $0.00 |
| 2026-08-15 | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | Tax withholding | 2,724 | $57.70 |
| 2026-08-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Grant / award | 14,443 | $0.00 |
| 2026-08-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Tax withholding | 2,984 | $57.70 |
| 2026-08-14 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-08-14 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $57.60 |
| 2026-08-11 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Tax withholding | 1,619 | $57.02 |
| 2026-08-11 | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | Tax withholding | 1,410 | $57.02 |
| 2026-08-11 | LAUKIEN FRANK H | PRESIDENT & CEO | Tax withholding | 4,838 | $57.02 |
| 2026-08-10 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Tax withholding | 1,573 | $56.32 |
| 2026-08-10 | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | Tax withholding | 1,289 | $56.32 |
| 2026-08-10 | LAUKIEN FRANK H | PRESIDENT & CEO | Tax withholding | 4,564 | $56.32 |
| 2026-08-09 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Tax withholding | 1,904 | $53.41 |
| 2026-08-09 | Herman Gerald N | EXECUTIVE VICE PRESIDENT, CFO | Tax withholding | 1,600 | $53.41 |
| 2026-08-09 | LAUKIEN FRANK H | PRESIDENT & CEO | Tax withholding | 2,361 | $53.41 |
| 2026-07-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-07-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $60.25 |
| 2026-06-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-06-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $54.76 |
| 2026-05-15 | Bernard Thierry | Reporting person | Grant / award | 2,886 | $0.00 |
| 2026-05-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-05-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $43.90 |
| 2026-04-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-04-15 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $39.90 |
| 2026-03-13 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Option exercise | 2,000 | $22.19 |
| 2026-03-13 | Munch Mark | EXEC VP&PRES BRUKER NANO INC. | Open market sale | 2,000 | $35.44 |
| 2026-02-15 | FRANCIS LAURA | Reporting person | Grant / award | 4,520 | $0.00 |
| 2026-02-15 | Phillips Jack | Reporting person | Grant / award | 4,520 | $0.00 |
| 2026-02-15 | ORNELL JOHN A | Reporting person | Grant / award | 4,520 | $0.00 |
| 2026-02-15 | LINTON WILLIAM A | Reporting person | Grant / award | 4,520 | $0.00 |
| 2026-02-15 | Perkins Adelene Q | Reporting person | Grant / award | 4,520 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 07:13 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-16 | 4 | 2026-09-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-15 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-14 | 8-K | 2026-08-14 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-13 | 4 | 2026-08-11 | View on SEC.gov → |
Recent news
Headlines about BRKR (Bruker Corporation). Links open the publisher — we don’t host full articles.
-
Is It Too Late to Buy Bruker Corp (BRKR) After 5.7% Rally? GF Va
GuruFocus · 2026-10-21 -
Bruker Jumps 6.3% Amid Sector-Wide Rally
AlphaStreet · 2026-10-21 -
Bruker Corporation (BRKR) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-21 -
Behavioral Patterns of BRKR and Institutional Flows
Stock Traders Daily · 2026-10-21 -
Bruker Corporation (BRKR) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
Yahoo · 2026-10-20 -
Bruker stock gains 3.47 percent versus Xetra close at EUR 50.41
AD HOC NEWS · 2026-10-20 -
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock Series A Stock Price Prediction: Today, Tomorrow, Next Week (BRKRP)
Traders Union · 2026-10-19
No headlines in this category right now — try “All”.